Ciprofloxacin therapy for Mediterranean spotted fever.
We report the treatment of five patients with Mediterranean spotted fever with the antimicrobial agent ciprofloxacin. The treatment was administered intravenously for 2 days and then perorally for 8 days. All five patients were cured. These preliminary data seem to correlate with the in vitro activity of ciprofloxacin against Rickettsia conorii.
D000328:Adult; D001907:Boutonneuse Fever / Q000188:drug therapy*; D002939:Ciprofloxacin / Q000097:blood / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male
D002939:Ciprofloxacin